Stromal cell-derived factor-1 but not its receptor, CXCR4, gene variants increase susceptibility and pathological development of hepatocellular carcinoma

Clinical Chemistry and Laboratory Medicine

Volumn 47, Issue 4, 2009, Pages 412-418

  Chang, Chi Chung ^a   Chen, Shu Chen ^a   Hsieh, Yi Hsien ^b   Chen, Yi Chen ^a   Chen, Tzy Yen ^c   Chu, Yin Hung ^a   Ma, Hui Jen ^a   Chou, Ming Chih ^a   Tsai, Hsiu Ting ^a   Yang, Shun Fa ^a,c  

^a CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^b CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

CXCR4; Hepatocellular carcinoma (HCC); Single nucleotide polymorphism (SNP); Stromal cell derived factor 1 (SDF 1)

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; STROMAL CELL DERIVED FACTOR 1;

ADULT; ARTICLE; CANCER RISK; CANCER STAGING; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

CARCINOMA, HEPATOCELLULAR; CHEMOKINE CXCL12; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RECEPTORS, CXCR4; RISK FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 63849320797     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/CCLM.2009.092     Document Type: Article

References (39)

1. Bosch FX, Ribes J, Cleries R, Diaz M. Epidemiology of hepatocellular carcinoma. Clin Liver Dis 2005;9:191-211.
2. Department of Health, Republic of China. "Health statistics: II. Vital statistics." Taipei: Department of Health, 2007.
3. Leao-Filho GC, Lopes EP, Ferraz AA, Moura I, Pernambuco JR, Reis C, et al. Hepatitis G virus infection in patients with hepatocellular carcinoma in Recife, Brazil. Jpn J Clin Oncol 2007;37:632-6.
4. Tsai MC, Kee KM, Chen YD, Lin LC, Tsai LS, Chen HH, et al. Excess mortality of hepatocellular carcinoma and morbidity of liver cirrhosis and hepatitis in HCV-endemic areas in an HBV-endemic country: geographic variations among 502 villages in southern Taiwan. J Gastroenterol Hepatol 2007;22:92-8.
5. Chen TH, Chen CJ, Yen MF, Lu SN, Sun CA, Huang GT, et al. Ultrasound screening and risk factors for death from hepatocellular carcinoma in a high risk group in Taiwan. Int J Cancer 2002;98:257-61.
6. Chen CJ, Yu MW, Liaw YF. Epidemiological characteristics and risk factors of hepatocellular carcinoma. J Gastroenterol Hepatol 1997;12:S294-308.
7. Borish LC, Steinke JW. Cytokines and chemokines. J Allergy Clin Immunol 2003;111:S460-75.
8. Liu H, Pan Z, Li A, Fu S, Lei Y, Sun H, et al. Roles of chemokine receptor 4 (CXCR4) and chemokine ligand 12 (CXCL12) in metastasis of hepatocellular carcinoma cells. Cell Mol Immunol 2008;5:373-8.
9. Li W, Gomez E, Zhang Z. Immunohistochemical expression of stromal cell-derived factor-1 (SDF-1) and CXCR4 ligand receptor system in hepatocellular carcinoma. J Exp Clin Cancer Res 2007;26:527-33.
10. Sutton A, Friand V, Brule-Donneger S, Chaigneau T, Ziol M, Sainte-Catherine O, et al. Stromal cell-derived factor-1/chemokine (C-X-C motif) ligand 12 stimulates human hepatoma cell growth, migration, and invasion. Mol Cancer Res 2007;5:21-33.
11. Shi GY, Shi DJ, Lu WB, Chen YK, Tong XM. A study of CXCR4/SDF-1 in hepatocellular carcinoma and liver cirrhosis. Zhonghua Gan Zang Bing Za Zhi 2007;15:276-8.
12. Xue TC, Chen RX, Ye SL, Sun RX, Chen J, Tang ZY. Different expressions of chemokine receptors in human hepatocellular carcinoma cell lines with different metastatic potentials. Zhonghua Gan Zang Bing Za Zhi 2007;15:261-5.
13. Chu H, Zhou H, Liu Y, Liu X, Hu Y, Zhang J. Functional expression of CXC chemokine recepter-4 mediates the secretion of matrix metalloproteinases from mouse hepatocarcinoma cell lines with different lymphatic metastasis ability. Int J Biochem Cell Biol 2007;39: 197-205.
14. Schimanski CC, Bahre R, Gockel I, Muller A, Frerichs K, Horner V, et al. Dissemination of hepatocellular carcinoma is mediated via chemokine receptor CXCR4. Br J Cancer 2006;95:210-7.
15. Shirozu M, Nakano T, Inazawa J, Tashiro K, Tada H, Shinohara T, et al. Structure and chromosomal localization of the human stromal cell-derived factor 1 (SDF1) gene. Genomics 1995;28:495-500.
16. Apostolakis S, Baritaki S, Kochiadakis GE, Igoumenidis NE, Panutsopulos D, Spandidos DA. Effects of polymorphisms in chemokine ligands and receptors on susceptibility to coronary artery disease. Thromb Res 2007; 119:63-71.
17. Soriano A, Martinez C, Garcia F, Plana M, Palou E, Lejeune M, et al. Plasma stromal cell-derived factor (SDF)-1 levels, SDF1-3'A genotype, and expression of CXCR4 on T lymphocytes: their impact on resistance to human immunodeficiency virus type 1 infection and its progression. J Infect Dis 2002;186:922-31.
18. Hirata H, Hinoda Y, Kikuno N, Kawamoto K, Dahiya AV, Suehiro Y, et al. CXCL12 G801A polymorphism is a risk factor for sporadic prostate cancer susceptibility. Clin Cancer Res 2007;13:5056-62.
19. Vairaktaris E, Vylliotis A, Spyridonodou S, Derka S, Vassiliou S, Nkenke E, et al. A DNA polymorphism of stromal- derived factor-1 is associated with advanced stages of oral cancer. Anticancer Res 2008;28:271-5.
20. de Oliveira CE, Cavassin GG, Perim Ade L, Nasser TF, de Oliveira KB, Fungaro MH, et al. Stromal cell-derived factor-1 chemokine gene variant in blood donors and chronic myelogenous leukemia patients. J Clin Lab Anal 2007;21:49-54.
21. Razmkhah M, Doroudchi M, Ghayumi SM, Erfani N, Ghaderi A. Stromal cell-derived factor-1 (SDF-1) gene and susceptibility of Iranian patients with lung cancer. Lung Cancer 2005;49:311-5.
22. Razmkhah M, Talei AR, Doroudchi M, Khalili-Azad T, Ghaderi A. Stromal cell-derived factor-1 (SDF-1) alleles and susceptibility to breast carcinoma. Cancer Lett 2005; 225:261-6.
23. de Oliveira Cavassin GG, De Lucca FL, Delgado Andre N, Covas DT, Pelegrinelli Fungaro MH, Voltarelli JC, et al. Molecular investigation of the stromal cell-derived factor- 1 chemokine in lymphoid leukemia and lymphoma patients from Brazil. Blood Cells Mol Dis 2004;33:90-3.
24. Federsppiel B, Melhado IG, Duncan AM, Delaney A, Schappert K, Clark-Lewis I, et al. Molecular cloning of the cDNA and chromosomal localization of the gene for a putative seven-transmembrane segment (7-TMS) receptor isolated from human spleen. Genomics 1993;16: 707-12.
25. Cheong JY, Cho SW, Choi JY, Lee JA, Kim MH, Lee JE, et al. RANTES, MCP-1, CCR2, CCR5, CXCR1 and CXCR4 gene polymorphisms are not associated with the outcome of hepatitis B virus infection: results from a large scale single ethnic population. J Korean Med Sci 2007; 22:529-35.
26. Petersen DC, Glashoff RH, Shrestha S, Bergeron J, Laten A, Gold B, et al. Risk for HIV-1 infection associated with a common CXCL12 (SDF1) polymorphism and CXCR4 variation in an African population. J Acquir Immune Defic Syndr 2005;40:521-6.
27. Centers for Disease Control, Taiwan, 2007. http://www.cdc.gov.tw
28. Nahon P, Sutton A, Rufat P, Simon C, Trinchet JC, Gattegno L, et al. Chemokine system polymorphisms, survival and hepatocellular carcinoma occurrence in patients with hepatitis C virus-related cirrhosis. World J Gastroenterol 2008;14:713-9.
29. Nahon P, Sutton A, Rufat P, Faisant C, Simon C, Barget N, et al. Lack of association of some chemokine system polymorphisms with the risks of death and hepatocellular carcinoma occurrence in patients with alcoholic cirrhosis: a prospective study. Eur J Gastroenterol Hepatol 2007;19:425-31.
30. Park BL, Kim YJ, Cheong HS, Kim LH, Choi YH, Lee HS, et al. Association of common promoter polymorphisms of MCP1 with hepatitis B virus clearance. Exp Mol Med 2006;38:694-702.
31. Ishikawa T, Nakashiro K, Hara S, Klosek SK, Li C, Shintani S, et al. CXCR4 expression is associated with lymphnode metastasis of oral squamous cell carcinoma. Int J Oncol 2006;28:61-6.
32. Onoue T, Uchida D, Begum NM, Tomizuka Y, Yoshida H, Sato M. Epithelial-mesenchymal transition induced by the stromal cell-derived factor-1/CXCR4 system in oral squamous cell carcinoma cells. Int J Oncol 2006;29: 1133-8.
33. Uchida D, Begum NM, Tomizuka Y, Bando T, Almofti A, Yoshida H, et al. Acquisition of lymph node, but not distant metastatic potentials, by the overexpression of CXCR4 in human oral squamous cell carcinoma. Lab Invest 2004;84:1538-46.
34. Fuke H, Sugimoto K, Shiraki K, Tanaka J, Beppu T, Yoneda K, et al. Predictive factors for distant recurrence of HCV-related hepatocellular carcinoma after radiofrequency ablation combined with chemoembolization. Aliment Pharmacol Ther 2008;27:1253-60.
35. Changchien CS, Chen CL, Yen YH, Wang JH, Hu TH, Lee CM, et al. Analysis of 6381 hepatocellular carcinoma patients in southern Taiwan: prognostic features, treatment outcome, and survival. J Gastroenterol 2008;43: 159-70.
36. Kumar M, Kumar R, Hissar SS, Saraswat MK, Sharma BC, Sakhuja P, et al. Risk factors analysis for hepatocellular carcinoma in patients with and without cirrhosis: a case-control study of 213 hepatocellular carcinoma patients from India. J Gastroenterol Hepatol 2007;22: 1104-11.
37. Chen CH, Su WW, Yang SS, Chang TT, Cheng KS, Lin HH, et al. Long-term trends and geographic variations in the survival of patients with hepatocellular carcinoma: analysis of 11,312 patients in Taiwan. J Gastroenterol Hepatol 2006;21:1561-6.
38. Yano Y, Yamashita F, Kuwaki K, Fukumori K, Kato O, Yamamoto H, et al. Clinical features of hepatitis C virusrelated hepatocellular carcinoma and their association with alpha-fetoprotein and protein induced by vitamin K absence or antagonist-II. Liver Int 2006;26:789-95. 39. Zhou L, Rui JA, Wang SB, Chen SG, Qu Q, Chi TY, et al. Clinicopathological features, post-surgical survival and prognostic indicators of elderly patients with hepatocellular carcinoma. Eur J Surg Oncol 2006;32:767-72.
39. Firpi RJ, Nelson DR. Viral hepatitis: manifestations and management strategy. Hematology Am Soc Hematol Educ Program 2006:375-380.